Revisiting the Green Synthesis of Nanoparticles: Uncovering Influences of Plant Extracts as Reducing Agents for Enhanced Synthesis Efficiency and Its Biomedical Applications.
biocompatibility
biomedical application
green synthesis
medicinal plants
nanomaterials
surface functionalization
Journal
International journal of nanomedicine
ISSN: 1178-2013
Titre abrégé: Int J Nanomedicine
Pays: New Zealand
ID NLM: 101263847
Informations de publication
Date de publication:
2023
2023
Historique:
received:
02
05
2023
accepted:
03
08
2023
medline:
28
8
2023
pubmed:
25
8
2023
entrez:
25
8
2023
Statut:
epublish
Résumé
Conventional nanoparticle synthesis methods involve harsh conditions, high costs, and environmental pollution. In this context, researchers are actively searching for sustainable, eco-friendly alternatives to conventional chemical synthesis methods. This has led to the development of green synthesis procedures among which the exploration of the plant-mediated synthesis of nanoparticles experienced a great development. Especially, because plant extracts can work as reducing and stabilizing agents. This opens up new possibilities for cost-effective, environmentally-friendly nanoparticle synthesis with enhanced size uniformity and stability. Moreover, bio-inspired nanoparticles derived from plants exhibit intriguing pharmacological properties, making them highly promising for use in medical applications due to their biocompatibility and nano-dimension. This study investigates the role of specific phytochemicals, such as phenolic compounds, terpenoids, and proteins, in plant-mediated nanoparticle synthesis together with their influence on particle size, stability, and properties. Additionally, we highlight the potential applications of these bio-derived nanoparticles, particularly with regard to drug delivery, disease management, agriculture, bioremediation, and application in other industries. Extensive research on scientific databases identified green synthesis methods, specifically plant-mediated synthesis, with a focus on understanding the contributions of phytochemicals like phenolic compounds, terpenoids, and proteins. The database search covered the field's development over the past 15 years. Insights gained from this exploration highlight plant-mediated green synthesis for cost-effective nanoparticle production with significant pharmacological properties. Utilizing renewable biological resources and controlling nanoparticle characteristics through biomolecule interactions offer promising avenues for future research and applications. This review delves into the scientific intricacies of plant-mediated synthesis of nanoparticles, highlighting the advantages of this approach over the traditional chemical synthesis methods. The study showcases the immense potential of green synthesis for medical and other applications, aiming to inspire further research in this exciting area and promote a more sustainable future.
Sections du résumé
Background
UNASSIGNED
Conventional nanoparticle synthesis methods involve harsh conditions, high costs, and environmental pollution. In this context, researchers are actively searching for sustainable, eco-friendly alternatives to conventional chemical synthesis methods. This has led to the development of green synthesis procedures among which the exploration of the plant-mediated synthesis of nanoparticles experienced a great development. Especially, because plant extracts can work as reducing and stabilizing agents. This opens up new possibilities for cost-effective, environmentally-friendly nanoparticle synthesis with enhanced size uniformity and stability. Moreover, bio-inspired nanoparticles derived from plants exhibit intriguing pharmacological properties, making them highly promising for use in medical applications due to their biocompatibility and nano-dimension.
Objective
UNASSIGNED
This study investigates the role of specific phytochemicals, such as phenolic compounds, terpenoids, and proteins, in plant-mediated nanoparticle synthesis together with their influence on particle size, stability, and properties. Additionally, we highlight the potential applications of these bio-derived nanoparticles, particularly with regard to drug delivery, disease management, agriculture, bioremediation, and application in other industries.
Methodology
UNASSIGNED
Extensive research on scientific databases identified green synthesis methods, specifically plant-mediated synthesis, with a focus on understanding the contributions of phytochemicals like phenolic compounds, terpenoids, and proteins. The database search covered the field's development over the past 15 years.
Results
UNASSIGNED
Insights gained from this exploration highlight plant-mediated green synthesis for cost-effective nanoparticle production with significant pharmacological properties. Utilizing renewable biological resources and controlling nanoparticle characteristics through biomolecule interactions offer promising avenues for future research and applications.
Conclusion
UNASSIGNED
This review delves into the scientific intricacies of plant-mediated synthesis of nanoparticles, highlighting the advantages of this approach over the traditional chemical synthesis methods. The study showcases the immense potential of green synthesis for medical and other applications, aiming to inspire further research in this exciting area and promote a more sustainable future.
Identifiants
pubmed: 37621852
doi: 10.2147/IJN.S419369
pii: 419369
pmc: PMC10444627
doi:
Substances chimiques
Reducing Agents
0
Plant Extracts
0
Phenols
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
4727-4750Informations de copyright
© 2023 Singh et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Toxicol Res. 2016 Apr;32(2):95-102
pubmed: 27123159
Materials (Basel). 2015 Oct 29;8(11):7278-7308
pubmed: 28793638
Biomed Pharmacother. 2016 Oct;83:865-875
pubmed: 27505864
Biomolecules. 2021 Feb 17;11(2):
pubmed: 33671333
Curr Pharm Biotechnol. 2021;22(13):1794-1811
pubmed: 33208069
Sci Rep. 2022 Dec 10;12(1):21395
pubmed: 36496441
Spectrochim Acta A Mol Biomol Spectrosc. 2014 Jul 15;128:337-41
pubmed: 24681317
Biomolecules. 2020 Nov 26;10(12):
pubmed: 33256218
Colloids Surf B Biointerfaces. 2012 Mar 1;91:212-4
pubmed: 22119564
Biomolecules. 2020 May 19;10(5):
pubmed: 32438654
Biomolecules. 2020 Mar 09;10(3):
pubmed: 32182874
Nanomaterials (Basel). 2022 Jun 10;12(12):
pubmed: 35745352
J Nanobiotechnology. 2011 Sep 26;9:43
pubmed: 21943321
Curr Pharm Biotechnol. 2021;22(13):1705-1747
pubmed: 33845733
Bioprocess Biosyst Eng. 2017 Jun;40(6):943-957
pubmed: 28361361
Curr Pharm Biotechnol. 2021;22(6):823-847
pubmed: 33397235
J Control Release. 2023 Feb;354:746-754
pubmed: 36690037
Ecotoxicol Environ Saf. 2015 Oct;120:400-8
pubmed: 26122733
Chem Biol Interact. 2017 Aug 1;273:219-227
pubmed: 28647323
Int J Nanomedicine. 2014 Sep 15;9:4357-73
pubmed: 25258527
J Nanosci Nanotechnol. 2005 Jul;5(7):1141-7
pubmed: 16108441
Colloids Surf B Biointerfaces. 2013 Jul 1;107:227-34
pubmed: 23500733
J Huazhong Univ Sci Technolog Med Sci. 2016 Aug;36(4):480-486
pubmed: 27465320
Biomolecules. 2021 Jan 29;11(2):
pubmed: 33572968
Int J Mol Sci. 2022 Feb 04;23(3):
pubmed: 35163718
Trends Biotechnol. 2015 Sep;33(9):514-524
pubmed: 26277289
RSC Adv. 2019 Jan 28;9(7):3704-3714
pubmed: 35518070
J Colloid Interface Sci. 2015 Nov 1;457:141-7
pubmed: 26164245
Biomolecules. 2021 Dec 25;12(1):
pubmed: 35053179
Colloids Surf B Biointerfaces. 2009 Oct 15;73(2):219-23
pubmed: 19539452
Polymers (Basel). 2023 Jan 11;15(2):
pubmed: 36679271
Environ Health Perspect. 2011 Mar;119(3):a120-5
pubmed: 21356630
Nanomaterials (Basel). 2021 May 20;11(5):
pubmed: 34065254
Biomolecules. 2020 Nov 02;10(11):
pubmed: 33147820
Bioengineering (Basel). 2022 Oct 11;9(10):
pubmed: 36290509
Mater Sci Eng C Mater Biol Appl. 2014 Nov;44:278-84
pubmed: 25280707
J Clin Biochem Nutr. 2007 May;40(3):163-73
pubmed: 18398493
Front Microbiol. 2019 Apr 26;10:820
pubmed: 31110495
Beilstein J Nanotechnol. 2015 Aug 21;6:1769-80
pubmed: 26425429
RSC Adv. 2019 Aug 8;9(42):24539-24559
pubmed: 35527869
Curr Pharm Biotechnol. 2023;24(1):3-22
pubmed: 35549874
RSC Adv. 2020 Feb 5;10(10):5894-5904
pubmed: 35497427
J Nanobiotechnology. 2020 Jan 9;18(1):8
pubmed: 31918714
Acta Pharm Sin B. 2019 Jan;9(1):74-86
pubmed: 30766779
J Pharm Bioallied Sci. 2010 Oct;2(4):282-9
pubmed: 21180459
3 Biotech. 2016 Dec;6(2):118
pubmed: 28330190
Toxicol Sci. 2010 Nov;118(1):160-70
pubmed: 20713472
Saudi Pharm J. 2016 Jul;24(4):473-84
pubmed: 27330378
ACS Omega. 2020 Mar 02;5(10):5520-5528
pubmed: 32201844
Colloids Surf B Biointerfaces. 2010 Oct 1;80(1):26-33
pubmed: 20620889
Anal Chem. 2003 Apr 15;75(8):1805-11
pubmed: 12713037
Sci Rep. 2021 Jul 19;11(1):14734
pubmed: 34282244
Mater Sci Eng C Mater Biol Appl. 2019 Jun;99:783-793
pubmed: 30889753
Nanotechnology. 2016 Feb 12;27(6):065603
pubmed: 26762732
Nanoscale Adv. 2020 Aug 24;2(11):5046-5089
pubmed: 36132021
J Drug Target. 2018 Apr;26(4):296-310
pubmed: 28906159
Science. 2013 Feb 22;339(6122):971-5
pubmed: 23430657
Front Pharmacol. 2017 Oct 06;8:697
pubmed: 29056913
Cancer Nanotechnol. 2011;2(1-6):57-65
pubmed: 26069485
Carbohydr Polym. 2022 Jul 15;288:119351
pubmed: 35450623
Fresenius J Anal Chem. 2001 Dec;371(8):1063-9
pubmed: 11798098
Colloids Surf B Biointerfaces. 2010 Nov 1;81(1):81-6
pubmed: 20656463
J Nanobiotechnology. 2018 Oct 30;16(1):84
pubmed: 30373622
Biomater Biosyst. 2021 Aug 13;3:100023
pubmed: 36824307
Toxicol Sci. 2010 Nov;118(1):140-9
pubmed: 20705894
J Diabetes Sci Technol. 2010 Mar 01;4(2):312-9
pubmed: 20307391
Biomaterials. 2009 Oct;30(31):6341-50
pubmed: 19698986
Biomater Adv. 2022 Apr;135:212726
pubmed: 35475005
Appl Microbiol Biotechnol. 2018 Aug;102(16):6799-6814
pubmed: 29882162
Adv Drug Deliv Rev. 2003 Feb 24;55(3):403-19
pubmed: 12628324
Biotechnol Prog. 2006 Mar-Apr;22(2):577-83
pubmed: 16599579
Front Bioeng Biotechnol. 2022 Mar 07;10:855136
pubmed: 35330628
Nanotoxicology. 2011 Dec;5(4):502-16
pubmed: 21417802
Nanoscale Res Lett. 2010 Jun 15;5(8):1351-9
pubmed: 20676207
Org Med Chem Lett. 2014 Dec 29;4(1):18
pubmed: 25621198
Sci Rep. 2018 Sep 25;8(1):14368
pubmed: 30254325
PLoS One. 2019 Oct 31;14(10):e0224109
pubmed: 31671165
Biotechnol Adv. 2013 Mar-Apr;31(2):346-56
pubmed: 23318667
Int J Environ Res Public Health. 2022 Jan 07;19(2):
pubmed: 35055505
Colloids Surf B Biointerfaces. 2018 Nov 1;171:398-405
pubmed: 30071481
IET Nanobiotechnol. 2013 Sep;7(3):117-24
pubmed: 24028810
Eur J Pharm Biopharm. 2004 Mar;57(2):369-75
pubmed: 15018998
Acta Biomater. 2019 Aug;94:44-63
pubmed: 31082570
Sci Rep. 2022 Sep 28;12(1):16165
pubmed: 36171339
Saudi J Biol Sci. 2021 Oct;28(10):5674-5683
pubmed: 34588879
3 Biotech. 2020 Jan;10(1):23
pubmed: 31903318
Biotechnol Rep (Amst). 2014 Aug 13;4:42-49
pubmed: 28626661
Sci Rep. 2017 Jun 1;7(1):2612
pubmed: 28572579
J Pharm Bioallied Sci. 2012 Jan;4(1):27-42
pubmed: 22368396
Microb Pathog. 2016 Dec;101:1-11
pubmed: 27765621
Adv Colloid Interface Sci. 2009 Jan 30;145(1-2):83-96
pubmed: 18945421
Medicines (Basel). 2020 May 09;7(5):
pubmed: 32397520
J Microencapsul. 2000 Sep-Oct;17(5):599-614
pubmed: 11038119
Antioxidants (Basel). 2020 Jul 02;9(7):
pubmed: 32630721
Pest Manag Sci. 2020 Jun;76(6):2021-2029
pubmed: 31943745
Adv Colloid Interface Sci. 2016 Aug;234:132-141
pubmed: 27181393
Biomolecules. 2020 Jun 17;10(6):
pubmed: 32560534
ACS Nano. 2019 Feb 26;13(2):1849-1860
pubmed: 30673260
Spectrochim Acta A Mol Biomol Spectrosc. 2013 Aug;112:384-7
pubmed: 23686093
PLoS One. 2022 Aug 5;17(8):e0268184
pubmed: 35930607
Curr Pharm Biotechnol. 2021;22(13):1782-1793
pubmed: 33430726
IET Nanobiotechnol. 2015 Oct;9(5):314-23
pubmed: 26435286
Pharmacogn Mag. 2018 Jan;13(Suppl 4):S840-S844
pubmed: 29491642
Acta Naturae. 2014 Jan;6(1):35-44
pubmed: 24772325
Semin Cancer Biol. 2022 Nov;86(Pt 2):310-324
pubmed: 35787941